JAGSNPHARM — Jagsonpal Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual balance sheet for Jagsonpal Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2021 March 31st	R2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	637	471	1,146	1,479	1,288
Net Total Accounts Receivable
Net Total Receivables	127	156	249	157	132
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,186	1,091	1,646	1,993	1,612
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	233	226	243	93	848
Net Goodwill
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,648	1,642	1,949	2,171	2,783
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	370	270	276	191	259
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	390	315	361	297	383
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	1,258	1,328	1,589	1,874	2,400
Total Liabilities & Shareholders' Equity	1,648	1,642	1,949	2,171	2,783
Total Common Shares Outstanding